Baptistcare_acnc Group
This charity reports as part of the This Is An Acnc Approved Reporting Group Made Up Of Individual Charities. Reporting Group Members Submit A Group Annual Information Statement And Are Not Required To Submit Individual Annual Information Statements. Select The Charity's Name To Visit Their Register Entry Page. Read More About Group Reporting..
-
Public Benevolent Institution
-
Basic Religious Charity
-
Tax deductible (DGR)
-
Financial Report Consolidated
Key Information
Charity Status
Charity reporting is up to date.
Charity Size
XL
- Extra Small (<$50k)
- Small ($50k-$250k)
- Medium ($250k-$1m)
- Large ($1m-$10m)
- Very Large ($10m-$100m)
- Extra Large (>$100m)
Revenue $414.4m
Years in Operation
N/A
Operating State(s)
No reported operations
Overseas Operations
Not Operating Overseas
Number of Employees
3,329.9
FTE Employees
632
Volunteers
% Revenue from Govt.
69.8%
Revenue from Govt. ($289.1m)
Total Expenses
$465.8m
112.4% of Revenue
% Revenue from Donations
0.6%
Revenue from Donations ($2.4m)
Grants for Use in Aus.
$0.00
0% of Expenses
Grants for Use Outside Aus.
$0.00
0% of Expenses
% Employee Expenses
62.3%
Employee Expenses ($290.1m)
More Details
Basic Information
Fundraising Status
- Conducts fundraising
Licence Number:
ACT: 0.0, SA: 0.0, TAS: 0.0, WA: 0.0
Purpose statement
The Centre for Eye Research Australia (CERA) is an independent Medical Research Institute deeply committed to conducting eye research with real-life impact and finding ways to prevent people from going blind. As an international leader in eye research, we use our world-class knowledge and expertise to achieve better treatments and faster diagnosis of eye disease. Our goal is to prevent vision loss and ultimately, find cures to restore sight. As true innovators, our scientists are on the brink of new discoveries every day. Cerulea Clinical Trials, a fully owned not-for-profit subsidiary of CERA, specialises in advanced therapeutics to prevent and treat blindness, including gene and cell therapies, biologics and medical devices. The skilled team is testing new therapies for eye conditions such as age-related macular degeneration, diabetic eye disease, glaucoma, inherited retinal disease and other rare genetic eye conditions with a major focus on trialing new therapies for diseases that currently have no treatment or cure.
2023 Financial Data
This charity reports as a group for financial purposes, for contact information and address, please visit the individual group member pages from the links below.
2023 Revenue Breakdown
Total Revenue $414,352,000$414.4m
2023 Expenses Breakdown
Total Expenses $465,758,000$465.8m
Total Gross Income (incl. $90,446,000$90.4m of other income e.g. gains): $504,798,000$504.8m
Baptistcare_ACNC Group have a net surplus of $39,040,000$39m
2023 Assets Breakdown
Total Assets $1,732,393,000 $1.7b
2023 Liabilities Breakdown
Total Liabilities $1,513,169,000$1.5b
Baptistcare_ACNC Group have net assets of $219,224,000$219.2m
2023 People
Staff Costs
$290.1m
70.0% of Annual Revenue
Full Time Equivalent Employees
3329.94
Average Expense per Employee
$87.1k
Full Time Employees
1047
18% of Employees
Part Time Employees
3787
64% of Employees
Casual Employees
1073
18% of Employees
This organisation is supported by 632 volunteers.
| Charity Name | Group Name | ABN |
|---|---|---|
Baptcare Ltd |
Baptistcare_acnc Group |
12069130463 |
Baptistcare Wa Limited |
Baptistcare_acnc Group |
17138445819 |
The Trustee For The Gnocci Charitable Trust |
Baptistcare_acnc Group |
45861153185 |
Baptistcare Retirement Living Wa |
Baptistcare_acnc Group |
49000388385 |
Baptist Care (sa) Incorporated |
Baptistcare_acnc Group |
81257754846 |
Baptistcare |
Baptistcare_acnc Group |
90000049525 |
Baptistcare Community Housing Limited |
Baptistcare_acnc Group |
12667330065 |
